Publications

AD
Innate Immunity and Cell Death in Alzheimer's Disease
American Society for Neurochemistry, 20 Oct 2021
READ NOW
AD Biomarker
miRNAs as Therapeutic Tools in Alzheimer’s Disease
International Journal of Molecular Sciences, 01 Dec 2021
READ NOW
AD Biomarker
Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression
International Journal of Molecular Sciences, 04 Dec 2021
READ NOW
AD Biomarker
MicroRNAs as a Diagnostic Biomarker in Alzheimer’s Disease: Potential Roles and Characteristics
Global journal of intellectual & developmental disabilities, 14 Sep 2021
READ NOW
mRNA Vaccine
Influenza Viruses: Innate Immunity and mRNA Vaccines
Frontiers in Immunology, 31 Aug 2021
READ NOW
Diagnosis
Diagnostic and therapeutic biomarkers for Alzheimer’s disease in human‑derived platelets
Genes & Genomics, 12 Dec 2020
READ NOW

Posters & Presentations

Poster
BMD-001, a nanoparticle containing miR-485-3p antisense oligonucleotide, blocks Alzheimer’s disease progression
Alzheimer’s Association International Conference (AAIC) / July, 2022
Presentation
Overcoming the Blood–Brain Barrier for RNA therapeutics
RNA Leaders World Congress / March, 2022
Poster
Targeting microRNA-485-3p blocks Alzheimer's disease progression
Clinical Trials on Alzheimer's Disease (CTAD) / November, 2021
Poster
BMD-001, a nanoparticle containing miR-485-3p antisense oligonucleotide, attenuates disease progression in Amyotrophic Lateral Sclerosis
PACTALS 2021 NAGOYA / September, 2021
Poster
Targeting microRNA-485-3p blocks Alzheimer's disease progression
Alzheimer's Association International Conference (AAIC) / July, 2021